Elanco, the animal health division of Eli Lilly and Company, announced an agreement to acquire Lohmann SE (Lohmann Animal Health), a privately held feed additive and poultry vaccine maker headquartered in Cuxhaven, Germany. The acquisition will establish Elanco as a global poultry leader, solidify Elanco’s vaccine presence, broaden Elanco’s product offerings and significantly augment Elanco’s vaccine manufacturing capabilities, according to a company news release.  Read More

Leave a Reply